Journal Scans
Two Cycles of Escalated BEACOPP Followed by Four Cycles of ABVD Utilizing Early-Interim PET/CT Scan Is an Effective Regimen for Advanced High-Risk Hodgkin's Lymphoma
escBEACOPP/ABVP Regimen Is Tolerable in Advanced Hodgkin’s Lymphoma
A Avigdor, S Bulvik, I Levi, EJ Dann, N Shemtov, G Perez-Avraham, A Shimoni, A Nagler, I Ben-Bassat, A Polliack
20100001
2010 Jan 1
Ann Oncol
Two Cycles of Escalated BEACOPP Followed by Four Cycles of ABVD Utilizing Early-Interim PET/CT Scan Is an Effective Regimen for Advanced High-Risk Hodgkin's Lymphoma
Ann Oncol. 2010 Jan 1;[Epub Ahead of Print], A Avigdor, S Bulvik, I Levi, EJ Dann, N Shemtov, G Perez-Avraham, A Shimoni, A Nagler, I Ben-Bassat, A Polliack
TAKE-HOME MESSAGE
Abstract
SUMMARY
OncologySTAT Editorial Team
Escalated (esc) combination therapy with bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone (escBEACOPP) is a powerful chemotherapy regimen. In the treatment of advanced Hodgkin’s lymphoma (HL), it has improved tumor control and overall survival (OS) vs treatment with baseline BEACOPP plus cyclophosphamide, vincristine, procarbazine, and prednisone alternating with doxorubicin, bleomycin, vinblastine, and dacarbazine (COPP/ABVD). High levels of toxicity...
